熱門資訊> 正文
FibroBiologics announces $1.7M registered direct offering
2025-12-15 21:56
- FibroBiologics (NASDAQ:FBLG) announced on Monday that it has entered into an agreement for the issuance and sale of an aggregate of 5.23M shares of its common stock at an offering price of $0.33 per share in a registered direct offering priced at-the-market under Nasdaq rules.
- Concurrently, the company will issue unregistered warrants to purchase up to an aggregate of 5.23M shares of common stock at an exercise price of $0.33 per share.
- The closing of the offering is expected to occur on or about December 16, 2025, subject to the customary closing conditions.
- The company expects $1.7M in gross proceeds from the offering, intending to use it for working capital and general corporate purposes.
- The shares in the registered direct offering are being offered pursuant to a registration statement filed with the SEC on February 3, 2025, which became effective on February 10, 2025.
More on FibroBiologics
- FibroBiologics announces payoff of outstanding debt
- FibroBiologics raises $4M in gold-funded registered direct offering
- Seeking Alpha’s Quant Rating on FibroBiologics
- Historical earnings data for FibroBiologics
- Financial information for FibroBiologics
推薦文章
港股周報 | 超配中國！高盛稱中國股市26年大漲15%至20%；阿里稱堅定加大淘寶閃購投入
2026年展望 | 智能駕駛元年或開啟！特斯拉Robotaxi引爆賽道，港美股哪些標的值得佈局？
美股機會日報 | 重磅大考！「非農+關税裁決」今夜同台亮相；Meta宣佈將投資核電廠，OKLO等核電股盤前飆升！
一周財經日曆 | 美國12月CPI攜手「恐怖數據」來襲；華爾街大行啟動Q4財報季，臺積電財報或炸場！4只港股新股即將上市
一周IPO | 吃大肉！本周六只新股上市大漲，MINIMAX暴漲109%；BBSB INTL孖展倍數超8900倍，位列史上第三
財報前瞻 | 臺積電Q4營收料衝破萬億新臺幣！大摩喊話績前買入，2026年股價還能「繼續飛」嗎？
MiniMax上市首日漲超60%，阿里、米哈遊等投資方「躺贏」
特朗普大讚英特爾及CEO陳立武 股價盤后上漲
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
